您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Latanoprost-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Latanoprost-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Latanoprost-d4图片
规格:98%
分子量:436.6
包装与价格:
包装价格(元)
50ug电议
100ug电议
500ug电议
1mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22792
CAS:N/A
分子式:C26H36D4O5
分子量:436.6
溶解度:DMF: 100 mg/ml,DMSO: 50 mg/ml,Ethanol: 100 mg/ml,PBS (pH 7.2): 0.05mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Latanoprost-d4contains four deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of latanoprost by GC-or LC-mass spectrometry. Latanoprost is the isopropyl ester of 17-phenyl-13,14-dihydro prostaglandin F. It is a prodrug form of the free acid, which is a potent agonist of the FP receptor in the eye. Latanoprost reduces intraocular pressure in glaucoma patients with few side effects.1,2,3The EC50value of latanoprost for (free acid) for FP receptors is 3.6 nM.4


1.LindÉn, C., Nuija, E., and Alm, A.Effects on IOP restoration and blood-aqueous barrier after long term treatment with latanoprost in open angle glaucoma and ocular hypertensionBritish Journal of Ophthalmology81370-372(1997) 2.Camras, C.B., Alm, A., Watson, P., et al.Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patientsOphthalmology1031916-1924(1996) 3.Alm, A., Villumsen, J., TÖrnquist, P., et al.Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month studyOphthalmology1001312-1317(1993) 4.Stjernschantz, J., and Resul, B.Phenyl substituted prostaglandin analogs for glaucoma treatmentDrugs of the Future17691-704(1992)